Fast-Track approval for Covid-19 drug, vaccine: DCGI

The Drugs Controller General of India (DCGI) has said that it will provide fast-track approval of all the companies which have a drug or vaccine for Covid-19 treatment, an attempt to speed up research and development (R&D) that could offer treatment or cure for the disease.
Appljcation from companies will also be given “high priority” and that it will assist the companies in speeding up their research.

The DCGI has offered seven measures for speeding up the process, from giving fast-track approval for repurposed drug to waiving animal study and offering flexible pathways which earlier would have taken months.

The DCGI, in a note to various drug makers and industry lobbies, said that “companies or research firms which have protocol for repurposing old drugs will be given priority for review and approval, and that applications for clinical trial permission and applications for importing or manufacturing a drug or vaccine will be expedited.”

If any company has a drug or a vaccine approved for Covid-19 in any other country, then it can approach the DCGI directly and seek a fast-track marketing approval to sell in India. Further, the data requirement for animal toxicity study and clinical study might be waived. Aplications to import a drug for test and analysis used to check efficacy with original molecules will be processed within seven days.

  • Related Posts

    • Pharma
    • July 9, 2025
    • 99 views
    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The…

    • Pharma
    • July 9, 2025
    • 109 views
    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    That half-empty bottle of painkillers or expired anxiety pills in your drawer could do more harm than good and Apex drug regulatory body, CDSCO, has said it’s best to flush…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July